A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid TechnologiesTM (ALT®) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza®

Autor: Lopez-Toledano, Miguel A., Thorsteinsson, Thorsteinn, Daak, Ahmed, Maki, Kevin C., Johns, Colleen, Rabinowicz, Adrian L., Sancilio, Frederick D.
Zdroj: In Clinical Therapeutics March 2017 39(3):581-591
Databáze: ScienceDirect
Externí odkaz: